Systematic error detection in experimental high-throughput screening.

Area of Science:

• Pharmacology and Drug Discovery
• Biotechnology
• Statistical Analysis

Background:

• High-throughput screening (HTS) identifies potential drug candidates by measuring compound activity.
• Systematic errors in HTS assays can arise from technical, procedural, or environmental factors, potentially compromising hit selection.
• Existing error correction methods may introduce bias into datasets without systematic error.

Purpose of the Study:

• To evaluate statistical procedures for assessing the presence of systematic error in experimental HTS data.
• To determine the most reliable method for identifying systematic error before applying correction techniques.
• To enhance the accuracy of hit selection in drug discovery by ensuring appropriate error handling.

Main Methods:

• Three statistical tests were evaluated: the chi-squared goodness-of-fit test, Student's t-test, and Kolmogorov-Smirnov test.
• These tests were applied to raw HTS measurements and estimated hit distribution surfaces.
• The Discrete Fourier Transform (DFT) method preceded the Kolmogorov-Smirnov test for error assessment.

Main Results:

• The study compared the accuracy of the three statistical procedures across simulated and real HTS datasets with varying systematic errors.
• Performance analysis was conducted under diverse error conditions to identify the most robust assessment method.
• The results indicate that appropriate statistical methodology is crucial for accurate systematic error assessment.

Conclusions:

• Researchers should utilize the t-test to statistically validate the presence of systematic error in HTS data.
• Performing this assessment prior to applying error correction methods is essential.
• Implementing this pre-correction statistical validation significantly improves the quality and reliability of selected drug candidates.